Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Inhibitors of endothelial cell proliferation from Sumitomo

Oct. 4, 1996

Human Genome Sciences discloses novel approach to malignancy

Oct. 4, 1996

Anticancer MMP inhibitor enters clinical trials

Oct. 4, 1996

Takeda's anticancer drug pipeline reviewed

Sep. 27, 1996

Promising preclinical and clinical results for Genta's lead antisense compound

Sep. 27, 1996

Clinical benefits of p53 gene therapy

Sep. 27, 1996

Antisense compound displays activity in animal models of human cancer

Sep. 27, 1996

Clinical trial of gene therapy for malignant brain tumors

Sep. 27, 1996

ET-743 product overview and development update

Sep. 27, 1996

Japanese researchers report new antiangiogenic compound

Sep. 27, 1996

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...